Washington HB 1741: Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

Status: By resolution, reintroduced and retained in present status. (as of 2026-01-12)

State: Washington · Session: 2025-2026 · Bill: HB 1741

Sponsors: Thai, Couture, Davis, Duerr, Fey, Leavitt, Nance, Parshley, Paul, Simmons

View Washington HB 1741 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.